John Kwon

Array ( [id] => 872385 [patent_doc_number] => 07361655 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-22 [patent_title] => 'Pharmaceutically effective compounds' [patent_app_type] => utility [patent_app_number] => 10/889966 [patent_app_country] => US [patent_app_date] => 2004-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6732 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/361/07361655.pdf [firstpage_image] =>[orig_patent_app_number] => 10889966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 659210 [patent_doc_number] => RE039267 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2006-09-05 [patent_title] => 'Thienopyrimidine-based inhibitors of the SRC family' [patent_app_type] => reissue [patent_app_number] => 10/878140 [patent_app_country] => US [patent_app_date] => 2004-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 27975 [patent_no_of_claims] => 96 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/039/RE039267.pdf [firstpage_image] =>[orig_patent_app_number] => 10878140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 543365 [patent_doc_number] => 07166592 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-23 [patent_title] => 'Nonsteroidal antiinflammatory agents' [patent_app_type] => utility [patent_app_number] => 10/874485 [patent_app_country] => US [patent_app_date] => 2004-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23681 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/166/07166592.pdf [firstpage_image] =>[orig_patent_app_number] => 10874485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6978561 [patent_doc_number] => 20050288279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Phenothiazine derivatives and their method of use' [patent_app_type] => utility [patent_app_number] => 10/875864 [patent_app_country] => US [patent_app_date] => 2004-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16176 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288279.pdf [firstpage_image] =>[orig_patent_app_number] => 10875864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7329992 [patent_doc_number] => 20040254180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammals' [patent_app_type] => new [patent_app_number] => 10/869516 [patent_app_country] => US [patent_app_date] => 2004-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9525 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254180.pdf [firstpage_image] =>[orig_patent_app_number] => 10869516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7435207 [patent_doc_number] => 20040266774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Amide compounds' [patent_app_type] => new [patent_app_number] => 10/866128 [patent_app_country] => US [patent_app_date] => 2004-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13003 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266774.pdf [firstpage_image] =>[orig_patent_app_number] => 10866128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7330765 [patent_doc_number] => 20040254371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'New benzothiazine and benzothiadiazine compounds' [patent_app_type] => new [patent_app_number] => 10/865185 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7002 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254371.pdf [firstpage_image] =>[orig_patent_app_number] => 10865185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7075283 [patent_doc_number] => 20050148551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => '7, 8 and 9-substituted tetracycline compounds' [patent_app_type] => utility [patent_app_number] => 10/866220 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8329 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148551.pdf [firstpage_image] =>[orig_patent_app_number] => 10866220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 446405 [patent_doc_number] => 07253162 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-07 [patent_title] => 'Benzothiazine and benzothiadiazine compounds' [patent_app_type] => utility [patent_app_number] => 10/865184 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7629 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/253/07253162.pdf [firstpage_image] =>[orig_patent_app_number] => 10865184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 247126 [patent_doc_number] => 07585878 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-08 [patent_title] => 'Benzamide derivative or salt thereof' [patent_app_type] => utility [patent_app_number] => 10/560282 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36863 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/585/07585878.pdf [firstpage_image] =>[orig_patent_app_number] => 10560282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5925051 [patent_doc_number] => 20060241304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Method for preparing fused oxazinones' [patent_app_type] => utility [patent_app_number] => 10/554090 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25345 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20060241304.pdf [firstpage_image] =>[orig_patent_app_number] => 10554090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 826916 [patent_doc_number] => 07402581 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-22 [patent_title] => 'Azetidine compounds' [patent_app_type] => utility [patent_app_number] => 10/560319 [patent_app_country] => US [patent_app_date] => 2004-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27902 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/402/07402581.pdf [firstpage_image] =>[orig_patent_app_number] => 10560319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844435 [patent_doc_number] => 20060122173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Il-8 receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/559154 [patent_app_country] => US [patent_app_date] => 2004-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7409 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122173.pdf [firstpage_image] =>[orig_patent_app_number] => 10559154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7378812 [patent_doc_number] => 20040220235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Method of inhibiting amyloid protein aggregation and imaging amyloid deposits' [patent_app_type] => new [patent_app_number] => 10/858912 [patent_app_country] => US [patent_app_date] => 2004-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27677 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220235.pdf [firstpage_image] =>[orig_patent_app_number] => 10858912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 428704 [patent_doc_number] => 07268138 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-11 [patent_title] => 'Compounds, methods and pharmaceutical compositions for inhibiting PARP' [patent_app_type] => utility [patent_app_number] => 10/853714 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 27418 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/268/07268138.pdf [firstpage_image] =>[orig_patent_app_number] => 10853714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7265022 [patent_doc_number] => 20040242558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Pyridylether derivatives, their preparation and use' [patent_app_type] => new [patent_app_number] => 10/848132 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8081 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242558.pdf [firstpage_image] =>[orig_patent_app_number] => 10848132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5843367 [patent_doc_number] => 20060121551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Novel phenoxazinone derivatives as enzyme substrates and use thereof as indicator in the detection of microorganisms with peptidase activity' [patent_app_type] => utility [patent_app_number] => 10/554461 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12565 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121551.pdf [firstpage_image] =>[orig_patent_app_number] => 10554461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 616593 [patent_doc_number] => 07145005 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-05 [patent_title] => '2-(6-{2-[(2R)-2-Methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one salts and their preparation' [patent_app_type] => utility [patent_app_number] => 10/843917 [patent_app_country] => US [patent_app_date] => 2004-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 14000 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/145/07145005.pdf [firstpage_image] =>[orig_patent_app_number] => 10843917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5643282 [patent_doc_number] => 20060281737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Cyclohexyl sulphones as gamma-secreatase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/555034 [patent_app_country] => US [patent_app_date] => 2004-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18077 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281737.pdf [firstpage_image] =>[orig_patent_app_number] => 10555034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7265051 [patent_doc_number] => 20040242587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Pyrrolo[1,2-b]pyridazine compounds' [patent_app_type] => new [patent_app_number] => 10/839051 [patent_app_country] => US [patent_app_date] => 2004-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15513 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242587.pdf [firstpage_image] =>[orig_patent_app_number] => 10839051 [rel_patent_id] =>[rel_patent_doc_number] =>)